Information for "Obinutuzumab (GA101)"
Jump to navigation
Jump to search
View the protection log for this page.
Basic information
| Display title | Obinutuzumab (GA101) |
| Redirects to | Obinutuzumab (Gazyva) (info) |
| Default sort key | Obinutuzumab (GA101) |
| Page length (in bytes) | 35 |
| Page ID | 236 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | PeterYang (talk | contribs) |
| Date of page creation | 04:58, 22 February 2012 |
| Latest editor | PeterYang (talk | contribs) |
| Date of latest edit | 13:10, 18 December 2013 |
| Total number of edits | 6 |
| Total number of distinct authors | 2 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |